NSEShareholders meetingM&A15 Jul 2026
Alkem Laboratories Limited
Shareholders meeting
Alkem Laboratories Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on August 17, 2026, to consider and approve the Scheme of Amalgamation between Alkem Laboratories Limited and Adroit Biomed Limited.
NSECopy of Newspaper Publication2 Jul 2026
Alkem Laboratories Limited
Copy of Newspaper Publication
Alkem Laboratories Limited has informed the Exchange about a Copy of Newspaper Publication regarding the 52nd Annual General Meeting to be held through video conferencing (VC)/other audio visual means (OAVM) on 27th August, 2026.
NSEAction(s) taken or orders passed▲ PositiveRegulatory1 Jul 2026
Alkem Laboratories Limited
Action(s) taken or orders passed
Alkem Laboratories Limited has received favourable Orders-in-Appeal from the Commissioner of Income Tax, Appeal – 47, Mumbai, deleting disallowances made under section 80-IE of the Income-tax Act, 1961, involving a tax amount of Rs. 660.77 Crores. The orders were received on 30th June, 2026.
NSECopy of Newspaper PublicationDividend30 Jun 2026
Alkem Laboratories Limited
Copy of Newspaper Publication
Alkem Laboratories Limited has informed the Exchange about a newspaper advertisement inviting shareholders to submit claims for unclaimed/unpaid Final Dividend for FY 2018-2019 and subsequent years, failing which shares would be transferred to Investor Education and Protection Fund Authority.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates29 Jun 2026
Alkem Laboratories Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Alkem Laboratories Limited has informed the Exchange about the schedule of an Analyst / Institutional Investor meeting to be held on 6th July, 2026, in Mumbai.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates29 Jun 2026
Alkem Laboratories Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Alkem Laboratories Limited has informed the Exchange about the schedule of an Analyst/Institutional Investor meeting to be conducted on 03rd July, 2026, for TA Associates.
NSEGeneral UpdatesM&A29 Jun 2026
Alkem Laboratories Limited
General Updates
Alkem Laboratories has informed the Exchange about an update on its acquisition of Occlutech Holding AG, a Swiss company, through its wholly-owned subsidiary Alkem Medtech Private Limited. The company has executed a First Supplementary Agreement to the Share Purchase Agreement dated 6th March, 2026, with the selling shareholders of Occlutech.
NSETrading Window24 Jun 2026
Alkem Laboratories Limited
Trading Window
Alkem Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.